A novel microtubule-modulating agent induces mitochondrially driven caspase-dependent apoptosis via mitotic

Ritu Aneja1, Tohru Miyagi, Prasanthi Karna

  • 1Department of Biology, Georgia State University, Atlanta, GA 30303, USA. raneja@gsu.edu

European Journal of Cancer (Oxford, England : 1990)
|March 23, 2010
PubMed

Insights

The novel compound EM011, a noscapine analogue, effectively inhibited hormone-refractory prostate cancer bone metastasis in mice. EM011 induced cancer cell death by disrupting cell division and activating apoptosis, with no observed toxicity in normal tissues.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Hormone-refractory prostate cancer with skeletal metastasis presents significant therapeutic challenges.
  • Existing treatments often have limited efficacy and considerable side effects.

Purpose of the Study:

  • To evaluate the efficacy of EM011, a novel brominated analogue of noscapine, against hormone-refractory prostate cancer.
  • To elucidate the mechanism of action of EM011 in prostate cancer cells.

Main Methods:

  • Treatment of intratibially implanted human prostate cancer in nude mice with EM011.
  • Non-invasive, real-time bioluminescent imaging to monitor tumor growth.
  • In vitro studies using human prostate cancer cell lines to assess antiproliferative and proapoptotic effects.
  • siRNA-mediated attenuation of the mitotic checkpoint.
  • Analysis of apoptotic pathways, including mitochondrial and caspase activation.

Main Results:

  • EM011 significantly inhibited hormone-refractory prostate cancer growth in bone.
  • EM011 induced G2/M cell-cycle arrest by impairing spindle apparatus formation, activating the mitotic checkpoint.
  • Mitotic checkpoint activation was crucial for EM011-induced apoptosis.
  • EM011 triggered an intrinsic, mitochondrially mediated apoptotic pathway involving caspase activation.
  • No detectable toxicity was observed in normal tissues with rapidly dividing cells.

Conclusions:

  • EM011 demonstrates potent anticancer activity against hormone-refractory prostate cancer with skeletal metastasis.
  • The compound's mechanism involves cell-cycle blockade and induction of apoptosis via mitochondrial and caspase pathways.
  • EM011 exhibits a favorable safety profile, warranting further clinical investigation for prostate cancer management.

Related Concept Videos

Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
Microtubule Instability02:17

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated assembly and...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.